NASDAQ: ZYNE Long Term Shareholder Notice: Investigation over Possible Wrongdoing at Zynerba Pharmaceuticals, Inc.
March 06, 2020 at 11:17 AM EST
San Diego, CA -- (SBWIRE) -- 03/06/2020 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Zynerba Pharmaceuticals, Inc..